Literature DB >> 18288567

Effects of human bone marrow stromal cell line (HFCL) on the proliferation, differentiation and apoptosis of acute myeloid leukemia cell lines U937, HL-60 and HL-60/VCR.

Rong Liang1, Gao-Sheng Huang2, Zhe Wang2, Xie-Qun Chen3, Qin-Xian Bai3, Yong-Qing Zhang3, Bao-Xia Dong3, Wen-Qing Wang3.   

Abstract

This study investigated the effects of human bone marrow fibroblastoid stromal cell line (HFCL) on the proliferation, differentiation and chemosensitivity of acute myeloid leukemia cells (AML) in vitro coculture. By setting up coculture system of sensitive U937, HL-60 cell line and multidrug-resistant (MDR) HL-60/VCR cells in direct contact with human bone marrow fibroblastoid stromal cell line HFCL, or separated by transwell, the proliferation of AML cells cocultured with HFCL cells was inhibited, compared with AML cells alone. And NBT positive cells increased slightly. The percentage of G1 phase cells of AML cells cocultured with HFCL cells was higher than that without HFCL cells, and that of S phase cells was lower. The expression of CD11b and CD14 increased. Meanwhile HL-60 and HL-60/VCR cells treated by TPT were observed to have apoptosis characteristic morphological changes. The proportion of G0/G1 HL-60 and HL-60/VCR cells treated with TPT increased and the sub-G1 increased. The percentage of Annexin V-positive cells and apoptotic cells increased with expression of activated Caspase-3 and the reduced expression of Bcl-2. But when they were cocultured with HFCL cells, the percentage of Annexin V-positive cells and apoptotic cells decreased and sub-G1 reduced. After indirect contact with HFCL cells the expression of activated Caspase-3 decreased and the expression of Bcl-2 increased. After direct contact with HFCL cells for 96 h, the expression levels of 582 genes in HL-60 cells were up-regulated, and 1,323 genes were down-regulated at least twofold by Affymetrix GeneChip Human Genome U133 set A. The expression change in some genes, such as HL14, was confirmed by RT-PCR and northern blot. In a word, HFCL cells could inhibit the proliferation, induce the monocytic differentiation of U937, HL-60 and HL-60/VCR cells, and prevent TPT-induced apoptosis in HL-60 and HL-60/VCR cells via modulation of Bcl-2 and active Caspase-3. Many genes might take part in the influence of HFCL cells on AML cells, which may give important insights into the interaction of bone marrow stromal cells and leukemic cells.

Entities:  

Mesh:

Year:  2008        PMID: 18288567     DOI: 10.1007/s12185-008-0030-6

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  28 in total

Review 1.  Survival of B lineage leukemic cells: signals from the bone marrow microenvironment.

Authors:  Laura F Gibson
Journal:  Leuk Lymphoma       Date:  2002-01

2.  p53 and redox state in etoposide-induced acute myeloblastic leukemia cell death.

Authors:  P Koistinen; T Siitonen; P Mäntymaa; E R Savolainen
Journal:  Leuk Res       Date:  2001-12       Impact factor: 3.156

3.  Lyn and Fgr protein-tyrosine kinases prevent apoptosis during retinoic acid-induced granulocytic differentiation of HL-60 cells.

Authors:  K Katagiri; K K Yokoyama; T Yamamoto; S Omura; S Irie; T Katagiri
Journal:  J Biol Chem       Date:  1996-05-10       Impact factor: 5.157

4.  Bone marrow stromal cells regulate caspase 3 activity in leukemic cells during chemotherapy.

Authors:  J E Fortney; W Zhao; S L Wenger; L F Gibson
Journal:  Leuk Res       Date:  2001-10       Impact factor: 3.156

5.  Differential gene expression in retinoic acid-induced differentiation of acute promyelocytic leukemia cells, NB4 and HL-60 cells.

Authors:  Ki-Hwan Lee; Mi-Yoon Chang; Joon-Ik Ahn; Dong-Hyun Yu; Sung-Soo Jung; Jung-Hye Choi; Yun-Hee Noh; Yong-Sung Lee; Myung-Ju Ahn
Journal:  Biochem Biophys Res Commun       Date:  2002-09-06       Impact factor: 3.575

6.  Stromal cells prevent apoptosis of AML cells by up-regulation of anti-apoptotic proteins.

Authors:  M Konopleva; S Konoplev; W Hu; A Y Zaritskey; B V Afanasiev; M Andreeff
Journal:  Leukemia       Date:  2002-09       Impact factor: 11.528

7.  Bone marrow stromal cells attenuate mitoxantrone cytotoxicity against HL-60 leukemic cells.

Authors:  A Takahashi; K Yamamoto; M Okuma; M Sasada
Journal:  Anticancer Drugs       Date:  1992-12       Impact factor: 2.248

8.  Mapping on human and mouse chromosomes of the gene for the beta-galactoside-binding protein, an autocrine-negative growth factor.

Authors:  A Baldini; T Gress; K Patel; R Muresu; L Chiariotti; P Williamson; Y Boyd; I Casciano; V Wells; C B Bruni
Journal:  Genomics       Date:  1993-01       Impact factor: 5.736

9.  Evaluation of chemosensitivity of human bone marrow stromal cells--differences between common chemotherapeutic drugs.

Authors:  Ralf Schmidmaier; Philipp Baumann; Bertold Emmerich; Gerold Meinhardt
Journal:  Anticancer Res       Date:  2006 Jan-Feb       Impact factor: 2.480

10.  Bone marrow adherent layers inhibit apoptosis of acute myeloid leukemia cells.

Authors:  L J Bendall; A Daniel; K Kortlepel; D J Gottlieb
Journal:  Exp Hematol       Date:  1994-12       Impact factor: 3.084

View more
  6 in total

1.  Human Adipose Tissue Stem Cells Promote the Growth of Acute Lymphoblastic Leukemia Cells in NOD/SCID Mice.

Authors:  Myoung Woo Lee; Yoo Jin Park; Dae Seong Kim; Hyun Jin Park; Hye Lim Jung; Ji Won Lee; Ki Woong Sung; Hong Hoe Koo; Keon Hee Yoo
Journal:  Stem Cell Rev Rep       Date:  2018-06       Impact factor: 5.739

Review 2.  Mesenchymal stem cells in acute myeloid leukemia: a focus on mechanisms involved and therapeutic concepts.

Authors:  Ezzatollah Fathi; Zohreh Sanaat; Raheleh Farahzadi
Journal:  Blood Res       Date:  2019-09-25

Review 3.  Modifying the tumour microenvironment and reverting tumour cells: New strategies for treating malignant tumours.

Authors:  Ya Qi Cheng; Shou Bi Wang; Jia Hui Liu; Lin Jin; Ying Liu; Chao Yang Li; Ya Ru Su; Yu Run Liu; Xuan Sang; Qi Wan; Chang Liu; Liu Yang; Zhi Chong Wang
Journal:  Cell Prolif       Date:  2020-06-26       Impact factor: 6.831

4.  Jagged1 contributes to the drug resistance of Jurkat cells in contact with human umbilical cord-derived mesenchymal stem cells.

Authors:  Yin Yuan; Xin Lu; Xuan Chen; Hongwei Shao; Shulin Huang
Journal:  Oncol Lett       Date:  2013-08-12       Impact factor: 2.967

Review 5.  Mesenchymal stem cells in suppression or progression of hematologic malignancy: current status and challenges.

Authors:  Myoung Woo Lee; Somi Ryu; Dae Seong Kim; Ji Won Lee; Ki Woong Sung; Hong Hoe Koo; Keon Hee Yoo
Journal:  Leukemia       Date:  2019-01-31       Impact factor: 11.528

6.  Establishment of a novel mesenchymal stem cell-based regimen for chronic myeloid leukemia differentiation therapy.

Authors:  Shiman Zuo; Luchen Sun; Yuxin Wang; Bing Chen; Jingyue Wang; Xiangyu Ge; Yan Lu; Nanfei Yang; Pingping Shen
Journal:  Cell Death Dis       Date:  2021-02-24       Impact factor: 8.469

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.